Glenmark Pharmaceuticals

Glenmark
Business

Glenmark introduces higher strength (400 mg) of FabiFlu(R) to reduce the pill burden of COVID-19 treatment

August 7, 2020 team Comments Off on Glenmark introduces higher strength (400 mg) of FabiFlu(R) to reduce the pill burden of COVID-19 treatment

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India. The higher strength […]

No Picture
Business

Glenmark commences 1000 patients Post Marketing Surveillance study with COVID-19 who are administered FabiFlu®

July 17, 2020 team Comments Off on Glenmark commences 1000 patients Post Marketing Surveillance study with COVID-19 who are administered FabiFlu®

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in 1000 patients […]